Canton Biologics
PrivateLast Round
Series C
Sep 13, 2023
Total Funding Raised
$56.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Canton Biologics operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series C round in September 2023.
Canton Biologics is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for biologic drugs, including monoclonal antibodies, bispecific antibodies, and recombinant proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Canton Biologics Comparables
Compare Canton Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioworkshops | 93% | |
| Chime Biologics | 92% | |
| MabPlex | 89% |
For institutional investors. Book with your work email.
Canton Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Canton Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guangdong Technology Financial Group | Series C |
| SDIC Venture Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2026
Open roles increased to 25, 2.3x the trailing average.
- Oct 12, 2026
Open roles increased to 19, 49% of headcount.
For institutional investors. Book with your work email.
Canton Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Canton Biologics's valuation, stock price, and market status.
Is Canton Biologics a public or private company?
Canton Biologics is a private company.
What is the current stock price of Canton Biologics?
Canton Biologics is a private company, so its shares have no public market price. Caplight tracks Canton Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Canton Biologics worth (valuation)?
Valuation information for Canton Biologics is not publicly available.
Can I buy Canton Biologics stock?
Canton Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Canton Biologics's last funding round?
Canton Biologics's most recent funding round was Series C on September 13, 2023.
Who are the main investors in Canton Biologics?
Key investors in Canton Biologics include SDIC Venture Capital.
Will Canton Biologics IPO soon?
No public IPO plans have been announced for Canton Biologics.
How can I track Canton Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Canton Biologics's shares on secondary markets.